Drug desensitization

From Citizendium
Revision as of 06:00, 9 August 2024 by Suggestion Bot (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

Drug desensitization is a technique for suppressing dangerous immune reactions to specific drugs, such that the drug may be used for treatment. It uses different approaches than allergy desensitization, intended to produce long-term effects. [1]

It is primarily directed at Type I, or immunoglobulin E-mediated, in the Gell and Coombs classification of immune reactions. The interaction of these with the drug causes degranulation of basophils and mast cells, which release or produce immune mediators such as histamine, prostaglandins, and leukotrienes. [2]

References

  1. "Drug Desensitization", Wake Forest School of Medicine
  2. Miriam K Anand and John M Route (21 April 2010), "Hypersensitivity Reactions, Immediate", eMedicine